Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Cipla
Baxter
QuintilesIMS
Chubb
AstraZeneca
Dow
Mallinckrodt

Generated: August 17, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: ibrutinib

« Back to Dashboard

IBRUTINIB

CASRN: 936563-96-1UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cipla
Daiichi Sankyo
Covington
US Army
Julphar
Fish and Richardson
Chubb
Moodys